Six patients with an early stage of gastrointestinal (GI) cancer (TINoMo, stage I) were successfully treated by photodynamic therapy (PDT) as follows: esophagus-1, stomach-2, rectum-3. The patients were photosensitized 72 hrs rior to treatment with pure venous infusion. Argon-pumped dye laser light
Photodynamic therapy in lung and gastrointestinal cancers
β Scribed by Strashimir Karanov; Dimitar Kostadinov; Maria Shopova; Panayot Kurtev
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 248 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1011-1344
No coin nor oath required. For personal study only.
β¦ Synopsis
Twelve central bronchial carcinoma patients and two gastrointestinal (GI) tract (oesophageal and colonic) early-stage cancer patients were treated with photodynamic therapy (PDT). Haematoporphyrin (HP/5, Jacopo Monico, Italy) at a dose of 5 mg kg-1 body weight was used as photosensitizer. Laser light at 628.2-630 nm generated by two different laser systems (gold vapour laser (I.P. Optics, Sofia, Bulgaria) in lung cancer cases and an argon dye laser system (Spectra Physics, Mountain View, U.S.A.) in GI tract cancers) was used. Lung cancers were irradiated 48 h after drug administration and GI tract cancers were irradiated 72 h after infusion of the photosensitizer. Both tumour sites were treated with a total energy dose in the range 350-600 J cm-2. Efficiency of PDT in lung cancer was evaluated by X-rays and endoscopic and functional respiratory tests for bronchial de-obstruction. Complete remission after PDT of GI tract cancers was considered to be tumour eradication (histologically and cytologically proved) and a tumour-free interval of at least 12 months.
π SIMILAR VOLUMES
Background and Objectives: PDT induces apoptosis, inflammatory reactions, immune reactions, and damage to the microvasculature around the tumors. The mechanisms responsible for the anticancer effects of Photofrin-PDT and NPe6-PDT differ somewhat. To select a photosensitizer for lung cancer treatment
## Abstract ## Background and Objective Endobronchial photodynamic therapy (PDT) is a minimally invasive technique for the palliation of major airway obstruction from lung cancer, and for the treatment of endobronchial microinvasive lung cancer. ## Study Design Results of reported clinical trial